BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27338827)

  • 1. NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.
    Boztug H; Hirschmugl T; Holter W; Lakatos K; Kager L; Trapin D; Pickl W; Förster-Waldl E; Boztug K
    J Clin Immunol; 2016 Aug; 36(6):533-40. PubMed ID: 27338827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired and Innate Immunity Impairment and Severe Disseminated
    Gonzalez-Granado LI; Ruiz-García R; Blas-Espada J; Moreno-Villares JM; Germán-Diaz M; López-Nevado M; Paz-Artal E; Toldos O; Rodriguez-Gil Y; de Inocencio J; Domínguez-Pinilla N; Allende LM
    Front Immunol; 2018; 9():3148. PubMed ID: 30761159
    [No Abstract]   [Full Text] [Related]  

  • 3. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
    Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
    Front Immunol; 2018; 9():2400. PubMed ID: 30386345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.
    Somekh I; Marquardt B; Liu Y; Rohlfs M; Hollizeck S; Karakukcu M; Unal E; Yilmaz E; Patiroglu T; Cansever M; Frizinsky S; Vishnvenska-Dai V; Rechavi E; Stauber T; Simon AJ; Lev A; Klein C; Kotlarz D; Somech R
    J Clin Immunol; 2018 Aug; 38(6):699-710. PubMed ID: 30030704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27.
    Salzer E; Daschkey S; Choo S; Gombert M; Santos-Valente E; Ginzel S; Schwendinger M; Haas OA; Fritsch G; Pickl WF; Förster-Waldl E; Borkhardt A; Boztug K; Bienemann K; Seidel MG
    Haematologica; 2013 Mar; 98(3):473-8. PubMed ID: 22801960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.
    Fliegauf M; Bryant VL; Frede N; Slade C; Woon ST; Lehnert K; Winzer S; Bulashevska A; Scerri T; Leung E; Jordan A; Keller B; de Vries E; Cao H; Yang F; Schäffer AA; Warnatz K; Browett P; Douglass J; Ameratunga RV; van der Meer JW; Grimbacher B
    Am J Hum Genet; 2015 Sep; 97(3):389-403. PubMed ID: 26279205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human NF-κB1 Haploinsufficiency and Epstein-Barr Virus-Induced Disease-Molecular Mechanisms and Consequences.
    Hoeger B; Serwas NK; Boztug K
    Front Immunol; 2017; 8():1978. PubMed ID: 29403474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pathogenic Missense Variant in
    Fliegauf M; Krüger R; Steiner S; Hanitsch LG; Büchel S; Wahn V; von Bernuth H; Grimbacher B
    Front Immunol; 2021; 12():621503. PubMed ID: 33995346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
    Latour S; Winter S
    Front Immunol; 2018; 9():1103. PubMed ID: 29942301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes.
    Kaustio M; Haapaniemi E; Göös H; Hautala T; Park G; Syrjänen J; Einarsdottir E; Sahu B; Kilpinen S; Rounioja S; Fogarty CL; Glumoff V; Kulmala P; Katayama S; Tamene F; Trotta L; Morgunova E; Krjutškov K; Nurmi K; Eklund K; Lagerstedt A; Helminen M; Martelius T; Mustjoki S; Taipale J; Saarela J; Kere J; Varjosalo M; Seppänen M
    J Allergy Clin Immunol; 2017 Sep; 140(3):782-796. PubMed ID: 28115215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel MALT1 Mutation Linked to Immunodeficiency, Immune Dysregulation, and an Abnormal T Cell Receptor Repertoire.
    Frizinsky S; Rechavi E; Barel O; Najeeb RH; Greenberger S; Lee YN; Simon AJ; Lev A; Ma CA; Sun G; Blackstone SA; Milner JD; Somech R; Stauber T
    J Clin Immunol; 2019 May; 39(4):401-413. PubMed ID: 31037583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.
    Lorenzini T; Fliegauf M; Klammer N; Frede N; Proietti M; Bulashevska A; Camacho-Ordonez N; Varjosalo M; Kinnunen M; de Vries E; van der Meer JWM; Ameratunga R; Roifman CM; Schejter YD; Kobbe R; Hautala T; Atschekzei F; Schmidt RE; Schröder C; Stepensky P; Shadur B; Pedroza LA; van der Flier M; Martínez-Gallo M; Gonzalez-Granado LI; Allende LM; Shcherbina A; Kuzmenko N; Zakharova V; Neves JF; Svec P; Fischer U; Ip W; Bartsch O; Barış S; Klein C; Geha R; Chou J; Alosaimi M; Weintraub L; Boztug K; Hirschmugl T; Dos Santos Vilela MM; Holzinger D; Seidl M; Lougaris V; Plebani A; Alsina L; Piquer-Gibert M; Deyà-Martínez A; Slade CA; Aghamohammadi A; Abolhassani H; Hammarström L; Kuismin O; Helminen M; Allen HL; Thaventhiran JE; Freeman AF; Cook M; Bakhtiar S; Christiansen M; Cunningham-Rundles C; Patel NC; Rae W; Niehues T; Brauer N; Syrjänen J; Seppänen MRJ; Burns SO; Tuijnenburg P; Kuijpers TW; ; Warnatz K; Grimbacher B;
    J Allergy Clin Immunol; 2020 Oct; 146(4):901-911. PubMed ID: 32278790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome.
    Padeira GL; Araújo C; Cordeiro AI; Freixo J; Martins CG; Neves JF
    Front Immunol; 2021; 12():654167. PubMed ID: 33995370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
    Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
    Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in
    Klemann C; Camacho-Ordonez N; Yang L; Eskandarian Z; Rojas-Restrepo JL; Frede N; Bulashevska A; Heeg M; Al-Ddafari MS; Premm J; Seidl M; Ammann S; Sherkat R; Radhakrishnan N; Warnatz K; Unger S; Kobbe R; Hüfner A; Leahy TR; Ip W; Burns SO; Fliegauf M; Grimbacher B
    Front Immunol; 2019; 10():297. PubMed ID: 30941118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?
    Fathi N; Mojtahedi H; Nasiri M; Abolhassani H; Yousefpour Marzbali M; Esmaeili M; Salami F; Biglari F; Rezaei N
    Expert Rev Clin Immunol; 2023 Mar; 19(3):329-339. PubMed ID: 36706462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
    Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
    Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations in
    Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
    Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.
    Worth AJ; Houldcroft CJ; Booth C
    Br J Haematol; 2016 Nov; 175(4):559-576. PubMed ID: 27748521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.
    Abolhassani H; Edwards ES; Ikinciogullari A; Jing H; Borte S; Buggert M; Du L; Matsuda-Lennikov M; Romano R; Caridha R; Bade S; Zhang Y; Frederiksen J; Fang M; Bal SK; Haskologlu S; Dogu F; Tacyildiz N; Matthews HF; McElwee JJ; Gostick E; Price DA; Palendira U; Aghamohammadi A; Boisson B; Rezaei N; Karlsson AC; Lenardo MJ; Casanova JL; Hammarström L; Tangye SG; Su HC; Pan-Hammarström Q
    J Exp Med; 2017 Jan; 214(1):91-106. PubMed ID: 28011864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.